Laboratorios Farmaceuticos Rovi/ ES0157261019 /
31.05.2024 07:57:08 | Diff. +0.3000 | Volumen | Geld22:00:00 | Brief22:00:00 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
88.1000EUR | +0.34% | - Umsatz: - |
87.4500Geld Vol: 30 | 88.0500Brief Vol: 30 | 88.1000 | 88.1000 |
GlobeNewswire
22:07
Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferr...
GlobeNewswire
22:05
TEN, Ltd. Announces Date of First Quarter 2024 Results, Conference Call and Webcast
GlobeNewswire
22:05
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc....
GlobeNewswire
22:05
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire
22:01
Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. Complete Merger
GlobeNewswire
22:01
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
21:35
Great Southern Bancorp, Inc. Announces Second Quarter 2024 Preliminary Earnings Release Date and Con...
GlobeNewswire
21:21
AAL INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into American Airl...
GlobeNewswire
21:09
Equinix Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
20:33
Federal Home Loan Bank of San Francisco Leads Two Roundtable Discussions with Rep. Pete Aguilar and ...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite